UPS Healthcare to Expand Global Facilities
The company is planning on adding up to 1.5 million sq. ft. of cGMP distribution space for COVID-19 shipments.
UPS Healthcare, a supply-chain solutions provider for the pharmaceutical and biopharmaceutical industries, announced on June 10, 2020 that it will complete a series of facility expansions to its healthcare-dedicated warehouse and distribution network.
According to a press release, the company is planning on adding up to 1.5 million ft2 of cGMP distribution space for COVID-19 shipments, including good distribution practice (GDP)-compliant spaces opening in central and eastern Europe, cold-chain space near its Worldport facility in Louisville, KY, and a new facility in Shanghai, China. UPS will also add additional cooler and freezer space to its GMP facility in Louisville.
“UPS Healthcare continues to build out a global distribution infrastructure that demonstrates our commitment to the healthcare industry,” said Wes Wheeler, UPS Healthcare president, in the press release. “We will continue to innovate and expand our quality systems throughout our expanded network to further support more complex pharmaceutical and lab testing requirements.”
Source: UPS Healthcare
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.
